Showing results (71-80 of 98) with videos related to
Sort By:
Pageof 10
BMC Psychiatry|July 28, 2018
Behavioral activation versus treatment as usual in naturalistic sample of psychiatric patients with depressive symptoms: a benchmark controlled trialKaisa E Luoto, Lars H Lindholm, Vesa Paavonen, et al.Frontiers in Psychiatry|October 25, 2021
Impact of Comorbid Alcohol Use Disorder on Health-Related Quality of Life Among Patients With Depressive SymptomsKaisa E Luoto, Lars H Lindholm, Antti Koivukangas, et al.Human Psychopharmacology|August 29, 2014
Polymorphism in alpha 2A adrenergic receptor gene is associated with sialorrhea in schizophrenia patients on clozapine treatmentAnssi Solismaa, Olli Kampman, Niko Seppälä, et al.Journal of Clinical Psychopharmacology|April 6, 2018
Genetic Polymorphisms Associated With Constipation and Anticholinergic Symptoms in Patients Receiving ClozapineAnssi Solismaa, Olli Kampman, Leo-Pekka Lyytikäinen, et al.The Journal of ECT|April 26, 2012
One-year follow-up after discontinuing maintenance electroconvulsive therapyKaija Huuhka, Merja Viikki, Tarja Tammentie, et al.Acta Neuropsychiatrica|January 10, 2018
BDNF and NRG1 polymorphisms and temperament in selective serotonin reuptake inhibitor-treated patients with major depressionKadri Andre, Olli Kampman, Merja Viikki, et al.The Journal of ECT|March 12, 2013
Effects of S-ketamine as an anesthetic adjuvant to propofol on treatment response to electroconvulsive therapy in treatment-resistant depression: a randomized pilot studyKaija Järventausta, Wojciech Chrapek, Olli Kampman, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|April 13, 2017
Histaminergic gene polymorphisms associated with sedation in clozapine-treated patientsAnssi Solismaa, Olli Kampman, Leo-Pekka Lyytikäinen, et al.Psychiatry Research|November 22, 2005
Changes in plasma amino acids after electroconvulsive therapy of depressed patientsJohanna Palmio, Martti Huuhka, Pirjo Saransaari, et al.Journal of Psychiatric Research|August 24, 2005
Epidermal growth factor a61g polymorphism is associated with the age of onset of schizophrenia in male patientsKari Hänninen, Heikki Katila, Sami Anttila, et al.Pageof 10